Morgan Stanley Bio Cardia, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.38 - $0.68 $171 - $306	450 New	450 $0
Q4 2023 Aug 16, 2024	BUY	$0.37 - $1.07 $166 - $481	450 New	450 $0
Q4 2023 Feb 13, 2024	SELL	$0.37 - $1.07 $197 - $570	-533 Reduced 54.22%	450 $0
Q4 2021 Feb 14, 2022	SELL	$25.65 - $46.05 $10,260 - $18,420	-400 Reduced 28.92%	983 $2,000
Q3 2021 Nov 15, 2021	BUY	$42.6 - $58.65 $58,915 - $81,112	1,383 New	1,383 $4,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.